Life Sciences
We help pharmaceutical and medical technology companies bring products to patients faster, prove their value to payers, and run compliant, reliable operations.
Our expertise
From pipeline to patient
Life sciences companies balance science, regulation, manufacturing and commercial realities, and decisions in one area quickly affect the others. We help drug and device makers make the strategic, commercial and operational decisions that follow, with research among clinicians, buyers and payers to ground them. Our work runs across the product lifecycle, from portfolio choices and development through launch, manufacturing and lifecycle management.
Industry trends
What is changing
Development costs more and takes longer
Science is more complex, success rates are low, and every failed program raises the cost of the ones that succeed.
Approval is no longer the finish line
Payers and health systems want evidence of clinical and economic value before they adopt a new therapy or device.
Pricing and reimbursement are under pressure
Policy changes and buyer consolidation put downward pressure on prices for drugs and devices alike.
More growth comes from outside
Licensing, partnerships and acquisitions supply a growing share of new products, alongside internal pipelines.
What we help with
Pharmaceuticals
We help biopharmaceutical companies, emerging biotechs and contract development and manufacturing organizations (CDMOs) across the product lifecycle, for small molecules and biologics alike.
01
Portfolio and pipeline strategy
Which assets and therapy areas to prioritize, license or divest, based on scientific promise, market potential and fit.
02
Launch and commercial models
Launch readiness, market access, pricing and the field model to support them, informed by research with prescribers and payers.
03
Quality, regulatory and manufacturing
Regulatory remediation, quality systems, tech transfer and supply reliability that keep products on the market and patients supplied.
04
Business development
Partner and target screening, due diligence and integration for licensing deals and acquisitions.
What we help with
Medical Technology
We help device, diagnostics and digital health companies grow in markets where health systems buy on outcomes and cost.
01
Product and portfolio strategy
Which products, segments and indications to pursue, informed by research with clinicians and buyers.
02
Value propositions for health systems
Evidence of clinical and economic value that procurement teams and value analysis committees accept.
03
Pricing and commercial models
Pricing, contracting and the mix of direct sales, distributors and service, by segment and region.
04
Connected and digital offerings
Business cases for connected devices, data services and software alongside the device, plus the quality and regulatory work they require.
Client questions
Questions clients bring us
- Which assets in our pipeline deserve the next round of investment?
- How do we prove our product’s value to payers and health systems before launch?
- Should we grow through licensing and acquisitions, or through internal R&D?
- How do we compete when hospitals buy mainly on price?
Explore other industries
Bringing new therapies and medical technologies to patients faster?
Tell us where in the lifecycle your question sits, and we will share how we would approach it.
